We would love to hear your thoughts about our site and services, please take our survey here.
Did hear it right in the latest VOX interview that the affimer reagent can be added into completed LFT kits without re-working? if this is the case, could manufacturers such as GAD/OMEGA etc be manufacturing blanks, to which the "latest version" of avactas potion could be added. in essence building a stockpile of blanks that can be released for "juicing" as required? would mean that if a new variant appears that needs a tweak, there isnt a huge stock of LFTs that wont detect. Hope this makes sense, it did in my head, but then my head is bettered today.
Just catching up on events. Reading on Twitter that avacta are in a close period, which I believe means no RNS until full year results out. Is that the case or can an RNS still be published? I’m not sure I can cope with no RNS potential every day, wonder if there is some kind of methodone type RNS substitute for this period.
"Now that we have developed a robust lateral flow test architecture, we can easily insert Affimer reagents that that can be very rapidly developed for new variants if necessary, and indeed in response to any other future pandemic virus."
given this section of the RNS id say we are in a great position to be able to cover off any variants that may come to light. This particular trait of the Avacta test gives me great confidence, and im sure it will also for potential customers. Buy and Hold for me.